Abstract:As a contribution to the development of new ruthenium complexes with pharmacologically interesting properties, two new mononuclear ruthenium(II) complexes of the general formula [Ru(H-Nap-sbdtc) Cl(CO)(EPh3)(2)] (1 & 2) [H-(Nap-sbdtc) = 2-hydroxy-1-naphthaldehyde-S-benzyl-dithiocarbazate; E = P or As] were synthesized. The new ruthenium(II) carbonyl complexes are remarkably stable and were obtained in good yields. Their identities have been established by satisfactory elemental analyses and various spectroscopic techniques (IR, UV/visible, (H-1, C-13, and P-31) NMR, and ESI-MS). For a better definition, the molecular structure of complexes 1 and 2 has been determined by X-ray crystallography, which confirms the coordination mode of the ligand and reveals a distorted octahedral geometry around the ruthenium ion. The molecular structure of complexes 1 and 2 has been optimized by DFT calculations. The binding affinity and binding mode of the ligand and their ruthenium(II) complexes toward calf thymus CT-DNA were determined by the emission spectral method, the fluorescent indicator displacement (FID) assay and viscosity measurements. Further, the interactions of the ligand and their complexes 1 and 2 with bovine serum albumin (BSA) were investigated using UV-Vis and fluorescence spectroscopic methods. Absorption and emission spectral studies indicate that complexes 1 and 2 interact with CT-DNA and BSA protein more strongly than their parent ligand. In addition, the interactions of the complexes with DNA/BSA were followed by electrophoretic mobility spectrometry studies and the results show that these complexes exhibited good cleavage properties. In vitro anticancer activity has been scrutinized by the MTT assay, acridine orange/ethidium bromide (AO/EB) and diamidino-2-phenylindole (DAPI) staining against the human cervical cancer (HeLa) cell line.

Novel Ruthenium‐based Nitrosyl Complexes: NO Donation and Vasorelaxant Potentials for Cardiovascular Therapeutics

In Situ FT-IR Spectroelectrochemistry Reveals Mechanistic Insights into Nitric Oxide Release from Ruthenium(II) Nitrosyl Complexes

Nitric oxide release and related light-induced cytotoxicity of ruthenium nitrosyls with coordinated nicotinate derivatives

Influence of diimine bidentate ligand in the nitrosyl and nitro terpyridine ruthenium complex on the HSA/DNA interaction and antiviral activity

Transition‐Metal Nitrosyls for Photocontrolled Nitric Oxide Delivery

Photorelease of Nitric Oxide (NO) in Mono- and Bimetallic Ruthenium Nitrosyl Complexes: A Photokinetic Investigation with a Two-Step Model

Kinetic-mechanistic studies of ruthenium macrocyclic complexes formation as potential donors and scavengers of nitric oxide and correlated species

Nitric oxide-triggering activity of gold-, platinum- and cerium oxide-nanozymes from S-nitrosothiols and diazeniumdiolates

A synergetic effect of light and anion: Near-infrared colorimetric monitoring of nitric oxide (NO) release from fluoride/cyanide anions and water responsive ruthenium nitrosyl complex

Synthesis, structure, spectra, cytotoxicity and photo induced NO release of four isomeric nitrosylruthenium complexes

Ruthenium(II) polypyridyl complexes with benzoxazole derivatives and non‐innocent ligands as effective antioxidants in human neuroblasts

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets

Ruthenium Nitrosyl Grafted Carbon Dots As A Fluorescence-Trackable Nanoplatform For Visible Light-Controlled Nitric Oxide Release And Targeted Intracellular Delivery

Photoinduced cytotoxic activity of a rare ruthenium nitrosyl phenanthroline complex showing NO generation in human cells

Insight into the anti-proliferation activity and photoinduced NO release of four nitrosylruthenium isomeric complexes and their HSA complex adducts

Unprecedented Formation Of Organo-Ruthenium(Ii) Complexes Containing 2-Hydroxy-1-Naphthaldehyde S-Benzyldithiocarbazate: Synthesis, X-Ray Crystal Structure, Dft Study And Their Biological Activities In Vitro

Novel Ruthenium Complexes Ligated with 4-Anilinoquinazoline Derivatives: Synthesis, Characterisation and Preliminary Evaluation of Biological Activity.

Vitamin B3 metal-organic frameworks as potential delivery vehicles for therapeutic nitric oxide

Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity

Carnosine analogues containing NO-donor substructures: synthesis, physico-chemical characterization and preliminary pharmacological profile

Biological Sensing of Nitric Oxide in Macrophages and Atherosclerosis Using a Ruthenium-Based Sensor